Logo image of ATEC

ALPHATEC HOLDINGS INC (ATEC) Stock Fundamental Analysis

NASDAQ:ATEC - US02081G2012 - Common Stock

15.865 USD
-0.28 (-1.7%)
Last: 8/25/2025, 2:26:58 PM
Fundamental Rating

2

Overall ATEC gets a fundamental rating of 2 out of 10. We evaluated ATEC against 185 industry peers in the Health Care Equipment & Supplies industry. ATEC may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ATEC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ATEC had negative earnings in the past year.
ATEC had a positive operating cash flow in the past year.
In the past 5 years ATEC always reported negative net income.
In the past 5 years ATEC always reported negative operating cash flow.
ATEC Yearly Net Income VS EBIT VS OCF VS FCFATEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

ATEC's Return On Assets of -21.00% is in line compared to the rest of the industry. ATEC outperforms 48.65% of its industry peers.
The Return On Equity of ATEC (-350.40%) is worse than 81.62% of its industry peers.
Industry RankSector Rank
ROA -21%
ROE -350.4%
ROIC N/A
ROA(3y)-24.42%
ROA(5y)-25.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATEC Yearly ROA, ROE, ROICATEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K

1.3 Margins

Looking at the Gross Margin, with a value of 68.81%, ATEC is in the better half of the industry, outperforming 75.68% of the companies in the same industry.
ATEC's Gross Margin has been stable in the last couple of years.
ATEC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.81%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y0.27%
ATEC Yearly Profit, Operating, Gross MarginsATEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

2

2. Health

2.1 Basic Checks

ATEC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATEC has about the same amount of shares outstanding.
The number of shares outstanding for ATEC has been increased compared to 5 years ago.
ATEC has a worse debt/assets ratio than last year.
ATEC Yearly Shares OutstandingATEC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ATEC Yearly Total Debt VS Total AssetsATEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ATEC has an Altman-Z score of 0.40. This is a bad value and indicates that ATEC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.40, ATEC is in line with its industry, outperforming 48.11% of the companies in the same industry.
ATEC has a Debt/Equity ratio of 11.65. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 11.65, ATEC is not doing good in the industry: 93.51% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 11.65
Debt/FCF N/A
Altman-Z 0.4
ROIC/WACCN/A
WACC7.79%
ATEC Yearly LT Debt VS Equity VS FCFATEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ATEC has a Current Ratio of 2.88. This indicates that ATEC is financially healthy and has no problem in meeting its short term obligations.
ATEC's Current ratio of 2.88 is in line compared to the rest of the industry. ATEC outperforms 57.30% of its industry peers.
ATEC has a Quick Ratio of 1.77. This is a normal value and indicates that ATEC is financially healthy and should not expect problems in meeting its short term obligations.
ATEC's Quick ratio of 1.77 is in line compared to the rest of the industry. ATEC outperforms 47.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.77
ATEC Yearly Current Assets VS Current LiabilitesATEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.44% over the past year.
The Revenue has grown by 26.27% in the past year. This is a very strong growth!
The Revenue has been growing by 40.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)24.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.83%
Revenue 1Y (TTM)26.27%
Revenue growth 3Y35.99%
Revenue growth 5Y40.08%
Sales Q2Q%27.46%

3.2 Future

The Earnings Per Share is expected to grow by 24.61% on average over the next years. This is a very strong growth
Based on estimates for the next years, ATEC will show a quite strong growth in Revenue. The Revenue will grow by 15.95% on average per year.
EPS Next Y20.82%
EPS Next 2Y22.16%
EPS Next 3Y24.62%
EPS Next 5YN/A
Revenue Next Year22.12%
Revenue Next 2Y20.18%
Revenue Next 3Y19.33%
Revenue Next 5Y15.95%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ATEC Yearly Revenue VS EstimatesATEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
ATEC Yearly EPS VS EstimatesATEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATEC. In the last year negative earnings were reported.
Also next year ATEC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATEC Price Earnings VS Forward Price EarningsATEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ATEC Per share dataATEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

ATEC's earnings are expected to grow with 24.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.16%
EPS Next 3Y24.62%

More info and screens

0

5. Dividend

5.1 Amount

ATEC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHATEC HOLDINGS INC

NASDAQ:ATEC (8/25/2025, 2:26:58 PM)

15.865

-0.28 (-1.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-28 2025-10-28/amc
Inst Owners63.91%
Inst Owner Change-0.61%
Ins Owners9.47%
Ins Owner Change-1.82%
Market Cap2.35B
Analysts81.18
Price Target19.33 (21.84%)
Short Float %11.04%
Short Ratio5.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-14.61%
Min EPS beat(2)-45.93%
Max EPS beat(2)16.71%
EPS beat(4)1
Avg EPS beat(4)-13.52%
Min EPS beat(4)-45.93%
Max EPS beat(4)16.71%
EPS beat(8)1
Avg EPS beat(8)-16.22%
EPS beat(12)1
Avg EPS beat(12)-19.49%
EPS beat(16)1
Avg EPS beat(16)-22.43%
Revenue beat(2)1
Avg Revenue beat(2)0.18%
Min Revenue beat(2)-1.38%
Max Revenue beat(2)1.74%
Revenue beat(4)3
Avg Revenue beat(4)0.31%
Min Revenue beat(4)-1.38%
Max Revenue beat(4)1.74%
Revenue beat(8)6
Avg Revenue beat(8)0.76%
Revenue beat(12)10
Avg Revenue beat(12)1.95%
Revenue beat(16)14
Avg Revenue beat(16)2.68%
PT rev (1m)3.47%
PT rev (3m)4.1%
EPS NQ rev (1m)18.96%
EPS NQ rev (3m)-32.59%
EPS NY rev (1m)-7.93%
EPS NY rev (3m)-2.91%
Revenue NQ rev (1m)1.13%
Revenue NQ rev (3m)1.76%
Revenue NY rev (1m)1.06%
Revenue NY rev (3m)1.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.44
P/FCF N/A
P/OCF 149.63
P/B 49.56
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)0.11
OCFY0.67%
SpS4.61
BVpS0.32
TBVpS-0.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21%
ROE -350.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.81%
FCFM N/A
ROA(3y)-24.42%
ROA(5y)-25.75%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.25%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity 11.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 55.75%
Cap/Sales 6.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.88
Quick Ratio 1.77
Altman-Z 0.4
F-Score5
WACC7.79%
ROIC/WACCN/A
Cap/Depr(3y)133.02%
Cap/Depr(5y)167.5%
Cap/Sales(3y)16.62%
Cap/Sales(5y)18.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.83%
EPS Next Y20.82%
EPS Next 2Y22.16%
EPS Next 3Y24.62%
EPS Next 5YN/A
Revenue 1Y (TTM)26.27%
Revenue growth 3Y35.99%
Revenue growth 5Y40.08%
Sales Q2Q%27.46%
Revenue Next Year22.12%
Revenue Next 2Y20.18%
Revenue Next 3Y19.33%
Revenue Next 5Y15.95%
EBIT growth 1Y33.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year315.61%
EBIT Next 3Y91.83%
EBIT Next 5Y64.84%
FCF growth 1Y75.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.46%
OCF growth 3YN/A
OCF growth 5YN/A